ISBN: 9780443139956 - Cell-based Cancer Immunotherapy (volume 183) (methods in Cell Biology, Volume 183) (6 results)

ISBN: 
Refine with Advanced Search

Refine your search

  • Books (6)

to

Custom price range (£)

to

  • Language: English

    Published by Academic Press, 2024

    0443139954 / 9780443139956

    • Hardcover

    Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices

    5-star seller
    Contact seller

    Condition: Used - As new

    £ 179.85

    £ 1.96 shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    Condition: As New. Unread book in perfect condition.

  • Language: English

    Published by Academic Press, 2024

    0443139954 / 9780443139956

    • Hardcover

    Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK

    5-star seller
    Contact seller

    Condition: Used - As new

    £ 181.75

    £ 15.00 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: Over 20 available

    Condition: As New. Unread book in perfect condition.

  • Language: English

    Published by Academic Press, 2024

    0443139954 / 9780443139956

    • Hardcover

    Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK

    5-star seller
    Contact seller

    Condition: New

    £ 196.28

    £ 15.00 shipping 
    Ships from United Kingdom to U.S.A.

    Quantity: Over 20 available

    Condition: New.

  • Language: English

    Published by Elsevier Science, 2024

    0443139954 / 9780443139956

    • Hardcover

    Seller: moluna, Greven, Germanymoluna

    5-star seller
    Contact seller

    Condition: New

    £ 175.56

    £ 40.90 shipping 
    Ships from Germany to U.S.A.

    Quantity: Over 20 available

    Condition: New. Provides comprehensive method articles from front-line experts on the topic of anticancer cellular immunotherapiesProvides useful schematic material and cutting-edge discussionsPresents the latest insights and future perspectives o.

  • Language: English

    Published by Academic Press, 2024

    0443139954 / 9780443139956

    • Hardcover

    Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices

    5-star seller
    Contact seller

    Condition: New

    £ 220.93

    £ 1.96 shipping 
    Ships within U.S.A.

    Quantity: Over 20 available

    Condition: New.

  • Language: English

    Published by Elsevier Inc Mär 2024, 2024

    0443139954 / 9780443139956

    • Hardcover

    Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH

    5-star seller
    Contact seller

    Condition: New

    £ 234.47

    £ 29.22 shipping 
    Ships from Germany to U.S.A.

    Quantity: 2 available

    Buch. Condition: Neu. Neuware - Cell-based Cancer Immunotherapy, Volume 183 provides the latest progress concerning research on anticancer cellular immunotherapies and their immunological, translation, or clinical aspects. Topics covered in this volume include Methods behind clinical DC vaccine products against glioblastoma, Fully closed and automated isolation of natural blood dendritic cells for cancer immunotherapy, Methods behind Oncolytic virus-based DC vaccines in cancer: towards a multiphase combined treatment strategy for Glioblastoma (GBM) patients, Identification of TCR repertoire patterns linked with anti-cancer immunotherapy, Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells, Methods behind neoantigen predictions for anticancer vaccines, Methods behind CD137L-DC-EBV-VAX anticancer vaccine, and much more. Additional sections cover Gold Standard Assessment of Immunogenic Cell Death Induced by Photodynamic Therapy: From In Vitro to Tumor Mouse Models and Anti-Cancer Vaccination Strategies, Methods behind TCR analyses for colorectal cancer-associated TILs, The use of xCELLigence, Incucyte, and/or Cr/LDH/maker-release assays, Humanized mouse models for anti-cancer therapy, In vitro re-challenge of CAR T cells, Methods behind adoptively transferred tumor draining lymphocytes for anticancer immunotherapy, and A murine glioblastoma platform to test cellular therapies with the standard of care.…